协同的MAPT突变作为一个平台来发现tau病原发生的修饰剂
bioRxiv : the preprint server for biology
|February 20, 2025
概括
研究人员开发了一种新的模型来研究阿尔茨海默病 (AD) 中的陶聚合. 热冲击蛋白70 (Hsp70) 被确定为tau聚合的关键驱动因素,提供潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 原生展开的陶蛋白的高溶解性使得在阿尔茨海默病 (AD) 中神经纤维状 (NFT) 病理学的建模复杂化.
- 热冲击蛋白 (Hsps) 在阿尔茨海默氏症的发病过程中的作用受到争议.
- 需要一个新的平台来研究tau聚合调节器.
研究的目的:
- 开发一种快速可靠的基于细胞的模型,用于研究聚.
- 研究热冲击蛋白 (Hsps) 在调节陶聚合中的作用.
- 通过了解tau聚合调节器来确定AD的潜在治疗点.
主要方法:
- 生成tau P301L和S320F (PL-SF) 突变模型以加速tau聚合.
- 在表达PL-SF突变的初级神经元中评估热冲击蛋白 (Hsp70,Hsc70,Hsp90).
- 使用shRNA降低Hsp70水平,并采用伴侣结合缺乏tau突变体 (PL-SF-4delta).
- 评估聚合性神经元中的神经元功能,包括发射和网络通信.
主要成果:
- 在初级神经元中,Hsp70表达加剧了tau聚合,与Hsc70或Hsp90.0.不同.
- 通过shRNA降低Hsp70水平或使用伴侣缺乏tau突变物显著降低了tau酸化和废除聚合.
- 具有成熟tau聚合物的神经元表现出神经元发射和网络通信受损.
- 缺少Chaperone结合的tau变体显示了tau病理的减少和恢复网络属性.
结论:
- 在与阿尔茨海默病相关的细胞模型中,hsp70是驱动tau聚合的关键内在因素.
- 开发的PL-SF tau模型是加速tau聚合研究和确定治疗点的强大工具.
- 调节Hsp70活动或准陶沙佩龙相互作用可能为AD提供新的治疗策略.
相关概念视频
Microtubule Associated Proteins (MAPs)
4.1K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.1K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Microtubule Instability
4.9K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
4.9K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


